Publication | Open Access
Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
60
Citations
86
References
2014
Year
PathologyCell DeathP53 RegulationCancer BiologyPhysiological RegulatorTumor BiologyGenomic InstabilityCell RegulationCancer Cell BiologyCancer ResearchTrp53 DeletionSystems BiologyCancer GeneticsCell BiologyRibosomal Protein S27-likeChromatinCancer GenomicsTumor SuppressorRps27l DisruptionMedicine
Cell-based studies showed that several Mdm2-binding ribosomal proteins, upon overexpression, stabilize and activate p53. In contrast, here we show in a mouse knockout study that Mdm2-binding ribosomal protein S27-like (Rps27l), upon disruption, activates p53. Germline inactivation of Rps27l triggers ribosomal stress to stabilize Mdm2, which degrades Mdm4 to reduce Mdm2-Mdm4 E3 ligase towards p53, leading to p53-dependent apoptotic depletion of hematopoietic stem cells and postnatal death, which is rescued by Trp53 deletion. Paradoxically, while increased p53 is expected to inhibit tumorigenesis, Rps27l⁻/⁻;Trp53⁺/⁻ mice develop lymphomas at higher incidence with p53 loss-of-heterozygosity and severe genome aneuploidy, suggesting that Rps27l disruption impose a selection pressure against p53. Thus, Rps27l has dual functions in p53 regulation: under Trp53⁺/⁺ background, Rps27l disruption triggers ribosomal stress to induce p53 and apoptosis, whereas under Trp53⁺/⁻ background, Rps27l disruption triggers genomic instability and Trp53 deletion to promote tumorigenesis. Our study provides a new paradigm of p53 regulation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1